Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

LON/0AAJ stock hub

LON/0AAJ has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0AAJis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.2B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0AAJ

In the news

Latest news · LON/0AAJ

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E86.1

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-6.1

P25 -54.2P50 2.1P75 13.7

ROIC2.1

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0AAJ market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

190

Groups with data

Currency

EUR

Showing 190 of 190 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Switzerland
Country code	UK
Employees	1,440
Employees Change	38%
Employees Change Percent	2.79
Enterprise value	CHF 1.3B
Exchange	London Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Biotechnology
Isin	CH1110760852
Last refreshed	2026-05-10
Market cap	CHF 1.2B
Price	CHF 40.8
Price currency	CHF
Rev Per Employee	235,859.95x
Sector	Healthcare
Sic	8731
Symbol	lon/0AAJ
Website	https://www.polypeptide.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1.5%
EV Earnings	-69.64x
EV/EBIT	172.8x
EV/EBITDA	34.07x
EV/FCF	-48.75x
EV/Sales	3.76x
FCF yield	-2.15%
Forward P/E	86.05x
P/B ratio	4.13x
P/S ratio	3.61x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	2.18%
EBITDA Margin	9.79%
Gross margin	16.77%
Gross Profit	CHF 57M
Gross Profit Growth	57.25%
Gross Profit Growth Q	85.72%
Gross Profit Growth3 Y	55.99%
Gross Profit Growth5 Y	39.32%
Net Income	CHF -18.5M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-5.15%
Profit Margin	-5.44%
Profit Per Employee	CHF -12,824
ROA	0.67
Roa5y	1.37
ROCE	1.32
ROE	-6.07
Roe5y	-1.31
ROIC	2.08
Roic5y	3.22

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	108.05%
Cagr3y	16.97%
EPS Growth Quarters	1
EPS Growth Years	0
OCF Growth	-13.3%
OCF Growth Q	-68.68%
OCF Growth10 Y	4.59%
OCF Growth3 Y	-3.13%
Revenue Growth	15.6x
Revenue Growth Q	10.15x
Revenue Growth Quarters	5x
Revenue Growth Years	3x
Revenue Growth3 Y	6.36x
Revenue Growth5 Y	6.88x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CHF 0.49
Assets	CHF 720.5M
Cash	CHF 65.1M
Current Assets	CHF 281M
Current Liabilities	CHF 161.4M
Debt	CHF 123.3M
Debt EBITDA	CHF 3.29
Debt Equity	CHF 0.42
Debt FCF	CHF -4.67
Equity	CHF 297.1M
Interest Coverage	0.49
Liabilities	CHF 423.4M
Long Term Assets	CHF 439.5M
Long Term Liabilities	CHF 262.1M
Net Cash	CHF -58.3M
Net Cash By Market Cap	CHF -4.75
Net Debt EBITDA	CHF 1.75
Net Debt Equity	CHF 0.2
Tangible Book Value	CHF 285M
Tangible Book Value Per Share	CHF 8.63
WACC	9.82

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.74
Inventory Turnover	2.16
Net Working Capital	CHF 61.6M
Quick ratio	0.87
Working Capital	CHF 120.7M
Working Capital Turnover	CHF 2.5

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.09%
Dividend per share	CHF 0
Last Dividend	CHF 0.25

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	107.95%
200-day SMA	26.76
3Y total return	60.06%
50-day SMA	30.36
50-day SMA vs 200-day SMA	50over200
All Time High	145
All Time High Change	-71.87%
All Time High Date	2022-01-03
All Time Low	13.82
All Time Low Change	195.22%
All Time Low Date	2025-04-07
ATR	1.56
Beta	1.02
Ch YTD	57.3
High	41.6
High52	41.6
High52 Date	2026-05-08
High52ch	-1.92%
Low	39.5
Low52	18.44
Low52 Date	2025-05-22
Low52ch	121.26%
Ma50ch	34.38%
Price vs 200-day SMA	52.47%
RSI	69.16
RSI Monthly	59.66
RSI Weekly	75.22
Sharpe ratio	1.55x
Sortino ratio	2.86
Total Return	-0.09%
Tr YTD	57.3
Tr1m	34.96%
Tr1w	4.35%
Tr3m	59.39%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CHF 7.4M
Operating Income Growth Q	235.4
Operating margin	2.18

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	12,958,106%
Net Borrowing	29,649,826.1
Shares Insiders	4.44%
Shares Institutions	10.29%
Shares Qo Q	-0.87%
Shares Yo Y	0.09%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CHF -28.1M
Average Volume	55,361.85x
Bv Per Share	9
CAPEX	CHF -94M
Ch1m	34.96
Ch1w	4.35
Ch1y	108
Ch3m	59.39
Ch3y	60.06
Ch6m	73.26
Change	0.12%
Change From Open	0.49
Close	40.75
Days Gap	-0.37
Depreciation Amortization	25,628,293.8
Dollar Volume	204,324.9
Earnings Date	2026-08-13
EBIT	CHF 7.4M
EBITDA	CHF 33.2M
EPS	CHF -0.56
F Score	5
FCF	CHF -26.4M
FCF EV Yield	-2.05x
Financing CF	29,479,225
Fiscal Year End	December
Founded	1,952
Income Tax	CHF 970,079
Investing CF	-97,452,777
Is Primary Listing	0
Last Earnings Date	2026-03-12
Last Report Date	2025-12-31
Ma150	27.26
Ma150ch	49.66%
Ma20	36.74
Ma20ch	11.06%
Net CF	5,506,418
Next Earnings Date	2026-08-13
Open	40.6
P OCF Ratio	18.15
Position In Range	61.89
Ppne	396,871,348.1
Price Date	2026-05-08
Price EBITDA	CHF 36.93
Ptbv Ratio	4.31
Relative Volume	0.09x
Revenue	339,638,324x
SBC By Revenue	0.52x
Share Based Comp	1,763,938
Tax By Revenue	0.29x
Tr6m	73.26%
Volume	5,008
Z Score	1.9

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0AAJ pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0AAJ stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0AAJ?

Insider, institutional, and short-interest positioning.

Institutional ownership

+10.3%

Share of float held by funds and institutions

Insider ownership

+4.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

LON/0AAJ momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

69.2

Neutral momentum band

Price vs 200-day MA

+52.5%

50/200-day relationship not available

Beta (5Y)

1.02

Moves roughly with the market

Sharpe ratio

1.55

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0AAJ

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0AAJ stock rating?

lon/0AAJ is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0AAJ analysis?

The full report lives at /stocks/lon/0AAJ/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0AAJ?

The latest report frames lon/0AAJ around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0AAJ page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.